Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Wohlleber

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
JHEP Reports : Innovation in Hepatology|April 25, 2022
High precision-cut liver slice model to study cell-autonomous antiviral defense of hepatocytes within their microenvironmentMarcus Brugger, Melanie Laschinger, Sandra Lampl, et al.
Journal of Hepatology|December 28, 2016
Liver sinusoidal endothelial cell cross-priming is supported by CD4 T cell-derived IL-2Michaela Wittlich, Michael Dudek, Jan P Böttcher, et al.
International Journal of Molecular Sciences|April 9, 2020
Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated HepatitisRike Schulte, Dirk Wohlleber, Ludmilla Unrau, et al.
Hepatology (Baltimore, Md.)|May 6, 2018
Outcome of Antiviral Immunity in the Liver Is Shaped by the Level of Antigen Expressed in Infected HepatocytesKatrin Manske, Nina Kallin, Verena König, et al.
Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.
Nature Communications|November 26, 2021
NUDT2 initiates viral RNA degradation by removal of 5'-phosphatesBeatrice T Laudenbach, Karsten Krey, Quirin Emslander, et al.
Scientific Reports|March 8, 2017
Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liverJulia Volckmar, Marcus Gereke, Thomas Ebensen, et al.
Oncoimmunology|July 30, 2016
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificityDavid Schirmer, Thomas G P Grünewald, Richard Klar, et al.
EMBO Reports|April 1, 2015
IAP antagonization promotes inflammatory destruction of vascular endotheliumAxel Witt, Jens M Seeger, Oliver Coutelle, et al.
Cells|July 3, 2020
MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
JHEP Reports : Innovation in Hepatology|April 25, 2022
High precision-cut liver slice model to study cell-autonomous antiviral defense of hepatocytes within their microenvironmentMarcus Brugger, Melanie Laschinger, Sandra Lampl, et al.
Journal of Hepatology|December 28, 2016
Liver sinusoidal endothelial cell cross-priming is supported by CD4 T cell-derived IL-2Michaela Wittlich, Michael Dudek, Jan P Böttcher, et al.
International Journal of Molecular Sciences|April 9, 2020
Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated HepatitisRike Schulte, Dirk Wohlleber, Ludmilla Unrau, et al.
Hepatology (Baltimore, Md.)|May 6, 2018
Outcome of Antiviral Immunity in the Liver Is Shaped by the Level of Antigen Expressed in Infected HepatocytesKatrin Manske, Nina Kallin, Verena König, et al.
Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.
Nature Communications|November 26, 2021
NUDT2 initiates viral RNA degradation by removal of 5'-phosphatesBeatrice T Laudenbach, Karsten Krey, Quirin Emslander, et al.
Scientific Reports|March 8, 2017
Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liverJulia Volckmar, Marcus Gereke, Thomas Ebensen, et al.
Oncoimmunology|July 30, 2016
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificityDavid Schirmer, Thomas G P Grünewald, Richard Klar, et al.
EMBO Reports|April 1, 2015
IAP antagonization promotes inflammatory destruction of vascular endotheliumAxel Witt, Jens M Seeger, Oliver Coutelle, et al.
Cells|July 3, 2020
MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Pageof 5